BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 49.16 Million | 48.46 Million | 39.18 Million | 22.78 Million | 37.79 Million | 46.15 Million |
| Cost of Revenue | 32.43 Million | 32.55 Million | 22.65 Million | 16.6 Million | 23.51 Million | 29.26 Million |
| Gross Profit | 16.72 Million | 15.91 Million | 16.52 Million | 6.17 Million | 14.28 Million | 16.89 Million |
| Operating Expenses | 34.66 Million | 41.24 Million | 32.64 Million | 24.7 Million | 29.9 Million | 35.09 Million |
| Selling, General and Administrative Expenses | 28.65 Million | 33.98 Million | 26.59 Million | 21.01 Million | 25.14 Million | 29.89 Million |
| Research and Development Expenses | 6 Million | 7.26 Million | 6.04 Million | 3.69 Million | 4.76 Million | 5.2 Million |
| Other Expenses | 48 Thousand | - | - | 4.21 Million | - | - |
| Cost and Expenses | 67.1 Million | 73.8 Million | 55.3 Million | 41.31 Million | 53.42 Million | 64.35 Million |
| Operating Income | -17.93 Million | -25.33 Million | -16.11 Million | -18.53 Million | -15.62 Million | -20.88 Million |
| Interest Expense | 2.36 Million | 2.74 Million | 2.22 Million | 2.35 Million | 2.15 Million | 510 Thousand |
| Income Tax Expense | 31 Thousand | 109 Thousand | 65 Thousand | 128 Thousand | -44 Thousand | 63 Thousand |
| Earnings before Tax | -20.6 Million | -28.52 Million | -16.09 Million | -16.7 Million | -17.89 Million | -21.45 Million |
| Net Income | -20.63 Million | -28.63 Million | -16.15 Million | -16.82 Million | -17.85 Million | -21.51 Million |
| Earnings Per Share Basic | -16.14 | -413.19 | -273.41 | -688.19 | -1923.95 | -2612.75 |
| Earnings Per Share Diluted | -16.14 | -413.19 | -273.41 | -688.19 | -1923.95 | -2612.75 |
| Weighted Average Shares Outstanding | 1.27 Million | 69.3 Thousand | 59.09 Thousand | 24.45 Thousand | 9280.40 | 8235.00 |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Million | 69.3 Thousand | 59.09 Thousand | 24.45 Thousand | 9280.40 | 8235.00 |
| Gross Margin | 0.34 | 0.33 | 0.42 | 0.27 | 0.38 | 0.37 |
| EBIT Margin | -0.31 | -0.51 | -0.40 | -0.61 | -0.39 | -0.37 |
| Profit Margin | -0.42 | -0.59 | -0.41 | -0.74 | -0.47 | -0.47 |
| EBITDA | -15.13 Million | -24.84 Million | -15.71 Million | -13.84 Million | -14.63 Million | -17.25 Million |
| Earnings Before Tax Margin | -0.36 | -0.52 | -0.41 | -0.81 | -0.41 | -0.45 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 11.55 Million | 10.13 Million | 13.49 Million | 49.16 Million | 10.92 Million | 14.28 Million |
| Cost of Revenue | 6.94 Million | 6.79 Million | 9.96 Million | 32.43 Million | 7.17 Million | 8.16 Million |
| Gross Profit | 4.6 Million | 3.33 Million | 3.52 Million | 16.72 Million | 3.74 Million | 6.11 Million |
| Operating Expenses | 7.82 Million | 7.86 Million | 8.6 Million | 34.66 Million | 7.44 Million | 9.99 Million |
| Selling, General and Administrative Expenses | 6.75 Million | 6.57 Million | 6.94 Million | - | 6.08 Million | 8.54 Million |
| Research and Development Expenses | 1.07 Million | 1.28 Million | 1.65 Million | - | 1.36 Million | 1.44 Million |
| Other Expenses | 1.14 Million | -1.22 Million | 167 Thousand | 48 Thousand | 28 Thousand | -147 Thousand |
| Cost and Expenses | 14.77 Million | 14.65 Million | 18.56 Million | 67.1 Million | 14.61 Million | 18.15 Million |
| Operating Income | -3.22 Million | -4.52 Million | -5.07 Million | -17.93 Million | -3.69 Million | -3.87 Million |
| Interest Expense | 586 Thousand | 622 Thousand | 603 Thousand | 2.36 Million | 598 Thousand | 583 Thousand |
| Income Tax Expense | 20 Thousand | 19 Thousand | -15 Thousand | 31 Thousand | 15 Thousand | 31 Thousand |
| Earnings before Tax | -2.77 Million | -6.46 Million | -5.34 Million | -20.6 Million | -4.57 Million | -4.83 Million |
| Net Income | -2.79 Million | -6.48 Million | -5.32 Million | -20.63 Million | -4.58 Million | -4.86 Million |
| Earnings Per Share Basic | -0.08 | -0.36 | -1.76 | - | -3.89 | -8.93 |
| Earnings Per Share Diluted | -0.08 | -0.36 | -1.76 | - | -3.89 | -8.93 |
| Weighted Average Shares Outstanding | 33.39 Million | 17.84 Million | 3.03 Million | 1.27 Million | 1.17 Million | 545 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 33.39 Million | 17.84 Million | 3.03 Million | 1.27 Million | 1.17 Million | 545 Thousand |
| Gross Margin | 0.40 | 0.33 | 0.26 | 0.34 | 0.34 | 0.43 |
| EBIT Margin | -0.12 | -0.38 | -0.33 | - | -0.34 | -0.18 |
| Profit Margin | -0.24 | -0.64 | -0.39 | -0.42 | -0.42 | -0.34 |
| EBITDA | -1.43 Million | -3.86 Million | -4.41 Million | - | -3.66 Million | -2.59 Million |
| Earnings Before Tax Margin | -0.28 | -0.45 | -0.38 | -0.36 | -0.34 | -0.27 |
1072
DOTZ3
VLXC
9435
PZOL
KALYANCAP